DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Gammaplex (Human Immunoglobulin G) - Published Studies


Gammaplex Related Published Studies

Well-designed clinical trials related to Gammaplex (Human Immunoglobulin G)

Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans. [2014]

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial. [2014]

Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine. [2012]

Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans. [2011.02]

Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans. [2011]

Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans. [2010.12]

Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica. [2010.11]

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. [2010.09]

Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers. [2010.04.30]

Reduction of PrP(C) in human cerebrospinal fluid after spinal cord injury. [2010.04]

A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma. [2010.01.08]

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. [2010]

A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma. [2010]

Immunomodulatory effects of a standardized Lycium barbarum fruit juice in Chinese older healthy human subjects. [2009.10]

A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs. [2009.09]

Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. [2009.08.06]

Alterations in the human lung proteome with lipopolysaccharide. [2009.05.11]

Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia. [2009.04]

Two doses of humanized anti-CD25 antibody in renal transplantation: a preliminary comparative study. [2009.01]

Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination. [2008.12.15]

Well-designed clinical trials possibly related to Gammaplex (Human Immunoglobulin G)

Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. [2015]

Long-term efficacy of a hepatitis E vaccine. [2015]

A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients. [2015]

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. [2015]

Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial. [2015]

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). [2014]

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial. [2014]

Rates of serious infections, opportunistic infections, inflammatory bowel disease, and malignancies in subjects receiving etanercept vs. controls from clinical trials in ankylosing spondylitis: a pooled analysis. [2014]

Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study. [2014]

Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis. [2014]

Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial. [2014]

The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trials. [2014]

Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. [2014]

Population exposure-response model to support dosing evaluation of ixekizumab in patients with chronic plaque psoriasis. [2014]

Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. [2014]

Development of Vi conjugate - a new generation of typhoid vaccine. [2013]

Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis. [2013]

Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy. [2013]

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax. [2013]

Randomized clinical trial of arginine-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing gastric cancer surgery. [2013]

Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. [2013]

Therapies for active rheumatoid arthritis after methotrexate failure. [2013]

The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: a double blind randomized study. [2013]

Etanercept in the treatment of ankylosing spondylitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials, and the comparison of the Caucasian and Chinese population. [2013]

Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. [2013]

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine vaccines in India. [2013]

Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study. [2013]

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study. [2012]

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study. [2012]

Allergen-specific oral immunotherapy for peanut allergy. [2012]

Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses. [2012]

Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis. [2012]

The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers. [2012]

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. [2012]

Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia. [2012]

Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial. [2012]

Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review. [2012]

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. [2012]

Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation. [2012]

Immunology in the Clinic Review Series; focus on allergies: immunotherapy for food allergy. [2012]

The safety and efficacy of sublingual and oral immunotherapy for milk allergy. [2012]

Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). [2012]

Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. [2012]

Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design. [2012]

High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study). [2011.10]

Treatment of neonatal sepsis with intravenous immune globulin. [2011.09.29]

Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials. [2011.08.24]

Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial. [2011.08.06]

Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis. [2011.08]

Pneumococcal conjugate vaccination at birth in a high-risk setting: no evidence for neonatal T-cell tolerance. [2011.07.26]

Evaluation of Early Enteral Feeding Through Nasogastric and Nasojejunal Tube in Severe Acute Pancreatitis: A Noninferiority Randomized Controlled Trial. [2011.07.14]

Sleep after vaccination boosts immunological memory. [2011.07.01]

Cost utility analysis based on a head-to-head Phase 3 trial comparing ustekinumab and etanercept in patients with moderate-to-severe plaque psoriasis: a Canadian perspective. [2011.07]

Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi. [2011.07]

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. [2011.07]

Efficacy of serology driven "test and treat strategy" for eradication of H. pylori in patients with rheumatic disease in the Netherlands. [2011.07]

Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. [2011.06.24]

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months. [2011.06.15]

Comparison of IVIg and PLEX in patients with myasthenia gravis. [2011.06.07]

Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial. [2011.06]

Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot study. [2011.06]

Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial. [2011.06]

Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia. [2011.05]

Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. [2011.05]

Impact of seroconversion and antichlamydial treatment on the rate of pre-eclampsia among Egyptian primigravidae. [2011.05]

99mTc-besilesomab (Scintimun) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells. [2011.05]

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE). [2011.05]

Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. [2011.05]

Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept. [2011.05]

Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. [2011.05]

Ingestion of micronutrient fortified breakfast cereal has no influence on immune function in healthy children: a randomized controlled trial. [2011.04.21]

Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. [2011.04.15]

Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D). [2011.04.11]

Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. [2011.04.05]

Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine. [2011.04.05]

Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. [2011.04]

Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children. [2011.04]

Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. [2011.04]

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. [2011.04]

House dust mite sublingual immunotherapy: results of a US trial. [2011.04]

Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study. [2011.04]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017